Zhang Cheng, Shao Yi-Ming, Ma Xiaohua, Cheong Siew Lee, Qin Chu, Tao Lin, Zhang Peng, Chen Shangying, Zeng Xian, Liu Hongxia, Pastorin Giorgia, Jiang Yuyang, Chen Yu Zong
Ministry-Province Jointly Constructed Base for State Key Lab and Shenzhen Technology and Engineering Lab for Personalized Cancer Diagnostics and Therapeutics, Tsinghua University Shenzhen Graduate School, and Shenzhen Kivita Innovative Drug Discovery Institute, Shenzhen 518055, PR China; Department of Molecular Pharmacology and Experimental Therapeutics, Center for Individualized Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Department of Pharmacy, National University of Singapore, Singapore 117543, Singapore.
J Mol Graph Model. 2017 Sep;76:136-142. doi: 10.1016/j.jmgm.2017.06.014. Epub 2017 Jul 11.
Conventional ligand and receptor similarity methods have been extensively used for exposing pharmacological relationships and drug lead discovery. They may in some cases neglect minor relationships useful for target hopping particularly against the remote family members. To complement the conventional methods for capturing these minor relationships, we developed a new method that uses a SLARC (Simultaneous Ligand And Receptor Clustering) 2D map to simultaneously characterize the ligand structural and receptor binding-site sequence relationships of a receptor family. The SLARC maps of the rhodopsin-like GPCR family comprehensively revealed scaffold hopping, target hopping, and multi-target relationships for the ligands of both homologous and remote family members. Their usefulness in new ligand discovery was validated by guiding the prospective discovery of novel indole piperazinylpyrimidine dual-targeting adenosine A2A receptor antagonist and dopamine D2 agonist compounds. The SLARC approach is useful for revealing pharmacological relationships and discovering new ligands at target family levels.
传统的配体和受体相似性方法已被广泛用于揭示药理学关系和药物先导物发现。在某些情况下,它们可能会忽略对靶点跳跃有用的次要关系,尤其是针对远亲成员。为了补充传统方法以捕捉这些次要关系,我们开发了一种新方法,该方法使用SLARC(同时配体和受体聚类)二维图来同时表征受体家族的配体结构和受体结合位点序列关系。视紫红质样GPCR家族的SLARC图全面揭示了同源和远亲家族成员配体的骨架跳跃、靶点跳跃和多靶点关系。通过指导新型吲哚哌嗪基嘧啶双靶点腺苷A2A受体拮抗剂和多巴胺D2激动剂化合物的前瞻性发现,验证了它们在新配体发现中的实用性。SLARC方法有助于在靶点家族水平揭示药理学关系并发现新配体。